Danaher Corp
Danaher Corp (DHR) Covered Calls
Danaher Corp trades in the Diagnostics & Research industry with an IV Rank of 44.25%, average versus the past year. DHR's highest covered call setup is the $250.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 7.29% out of the money with 7 days to expiration, a 7.33% return until expiration, and a 382.20% theoretical annualized return. Across the setups shown, annualized returns run from 176.33% to 382.20% at strikes between $240.00 and $280.00, with 7 to 35 days to expiration, as of Nov 13, 2026.
Read more
Running DHR covered calls helps you generate income from Danaher Corp shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best DHR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If DHR stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling DHR covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given DHR covered call is worth writing.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers.
| 2026-11-20 | 7 | 250.00 | 7.29 | 0.10 | 1.10 | 1708.00 | 7.33 | 382.20 | -0.04 | +0.10 | 914 | 1.00 |
| 2026-11-20 | 7 | 247.50 | 6.21 | 0.05 | 1.65 | 1453.00 | 6.24 | 325.14 | -0.02 | +0.14 | 3 | 1.60 |
| 2026-11-20 | 7 | 245.00 | 5.14 | 0.40 | 1.70 | 1238.00 | 5.31 | 277.03 | -0.17 | +0.17 | 288 | 1.30 |
| 2026-11-20 | 7 | 242.50 | 4.07 | 0.75 | 1.20 | 1023.00 | 4.39 | 228.92 | -0.32 | +0.18 | 97 | 0.45 |
| 2026-11-27 | 14 | 252.50 | 8.36 | 0.10 | 2.30 | 1958.00 | 8.40 | 219.07 | -0.04 | +0.14 | 0 | 2.20 |
| 2026-12-18 | 35 | 280.00 | 20.16 | 0.10 | 0.30 | 4708.00 | 20.20 | 210.70 | -0.04 | +0.03 | 588 | 0.20 |
| 2026-12-04 | 21 | 260.00 | 11.58 | 0.20 | 0.90 | 2718.00 | 11.66 | 202.74 | -0.09 | +0.07 | 1 | 0.70 |
| 2026-11-27 | 14 | 250.00 | 7.29 | 0.35 | 2.85 | 1733.00 | 7.44 | 193.90 | -0.15 | +0.18 | 129 | 2.50 |
| 2026-12-11 | 28 | 265.00 | 13.72 | 0.05 | 1.65 | 3203.00 | 13.75 | 179.18 | -0.02 | +0.09 | 0 | 1.60 |
| 2026-11-20 | 7 | 240.00 | 3.00 | 0.90 | 2.60 | 788.00 | 3.38 | 176.33 | -0.39 | +0.27 | 910 | 1.70 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryDiagnostics & Research
- SectorHealthcare
- IV Rank44.25% Moderate
- Market cap (M$)161,749
- 52 weeks high-5.31%
- 52 weeks low42.86%
- Analyst recommendationBuy
1.52 - Target price$260.43
13.27% above the current stock price - Dividend—
- Payout ratio25.36%
- Earnings date2027-01-27
- P/E37.65
- Future P/E24.69
- EPS (ttm)6.11
- EPS growth next 5 years9.49%
As of Nov 16, 2026